Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

Clinical trial NCT07609446 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07609446
Sponsor: The First Affiliated Hospital of Soochow University
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Indolent Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Indolent Mantle Cell Lymphoma

Start date: 2026-05-01
Primary completion: 2027-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.